ArticlePharmacoEconomics2026

Correction: Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma.

Huang-Tz Ou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.